Reserpine causes the release of 5-hydroxytryptamine (5-HT) from all tissues in which it is normally stored. This release is shown by a fall in the tissue concentration of 5-HT and by an increase in its urinary metabolites (Pletscher, Shore & Brodie, 1955;Shore, Silver & Brodie, 1955). That reserpine may also lower the concentration of catecholamines in tissues was shown by experiments (Holzbauer & Vogt, 1956) in which the disappearance of noradrenaline from the hypothalamus was demonstrated in cats injected with small doses of reserpine (0-4 mg/kg). This depletion, however, did not occur in all organs, the denervated, in contrast to the innervated, adrenal medulla remaining unaffected by this dose of the drug.It is tempting to try to correlate the effects on behaviour and responsiveness produced by reserpine with the loss of 5-HT and noradrenaline from the brain. The tendency has been to attribute not only the sedation, but also such signs as the fall in blood pressure, the miosis and the relaxation of the nictitating membrane to central changes alone. Although all these phenomena might be due to central causes, they could also be produced, at least partly, by disturbances in the peripheral sympathetic system. Failure of another sympathetic mechanism after reserpine was described by G. M. Everett who observed (personal communication, and Everett, Toman & Smith, 1957) that cold did not produce pilo-erection in mice injected with reserpine. This failure, too, might be due to a central or to a peripheral derangement, or to both.The aim of the present paper is to determine the effect of reserpine on the peripheral sympathetic tissues: the investigation, abstracts of which have been published (Muscholl & Vogt, 1957 a, b), deals with the loss of transmitter and the damage to function produced by reserpine in adrenergic neurones. In preliminary experiments the normal range of concentrations of adrenaline and noradrenaline in various parts of the sympathetic system was established.